Details of the Drug

General Information of Drug (ID: DM2NP0W)

Drug Name
DYV800
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Preclinical [1]
Cross-matching ID
TTD ID
DR6EK5

References

1 Clinical pipeline report, company report or official report of Dyve Biosciences